Our MoA solutions help you predict how your target affects real-life genes, proteins, regulators, pathways and more, without the need for extensive research and data processing. You can generate custom MoA networks for your target candidate or disease and predict adverse outcomes and toxicity before spending any time in the lab.
Our data has been standardized and reprocessed with strict quality control, so you can connect your data to specific biological insights.
After learning about your target's MoA, you need to link your experimental data with clinical pathology endpoints and understand pharmacological response. A drug could be a silver bullet against your target disease, but it could also involve significant downsides. Our curated data helps you verify that your targets are ready for the next stage of development and avoid costly missteps.
With our multiomics data and advanced pathway analysis software, you can efficiently create a comprehensive picture of your drug candidate's MoA and safety profile.
Spend less time on literature analysis and connect your data to relevant preprocessed studies
Identify potential safety issues and off-target effects early, minimizing late-stage clinical trial failure and increasing safety
Investigate potential applications for new or existing drugs in different therapeutic areas
Compare your target's MoA with known drugs, toxicity profiles and adverse outcomes to identify potential safety concerns
